Literature DB >> 21834078

Lipid apheresis, indications, and principles.

Jeffrey L Winters1.   

Abstract

Low-density lipoprotein apheresis (LDL apheresis) is a term that describes a group of apheresis techniques and devices that selectively remove apolipoprotein B containing lipoproteins. A number of different devices are available worldwide, which all effectively remove low-density lipoprotein cholesterol while sparing other important plasma components. LDL apheresis is used to treat familial hypercholesterolemia (FH), an inherited condition of accelerated atherosclerosis and severe coronary artery disease resulting in premature death. It has also been used to treat other disorders, although the evidence for its use is limited. This review describes the underlying pathophysiology of FH, the mechanism of action of the various LDL apheresis devices available, and how LDL apheresis is used to treat this uncommon metabolic condition.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21834078     DOI: 10.1002/jca.20299

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  7 in total

Review 1.  Lipoprotein apheresis to treat elevated lipoprotein (a).

Authors:  Elisa Waldmann; Klaus G Parhofer
Journal:  J Lipid Res       Date:  2016-02-17       Impact factor: 5.922

2.  Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment.

Authors:  Kurt Derfler; Sabine Steiner; Helmut Sinzinger
Journal:  Wien Klin Wochenschr       Date:  2015-07-23       Impact factor: 1.704

3.  The Italian Consensus Conferences on low density lipoprotein-cholesterol apheresis.

Authors:  Anja Vogt
Journal:  Blood Transfus       Date:  2016-07-07       Impact factor: 3.443

Review 4.  The genetics of familial hypercholesterolemia and emerging therapies.

Authors:  Anja Vogt
Journal:  Appl Clin Genet       Date:  2015-01-28

5.  LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late.

Authors:  Agnieszka Mickiewicz; Marcin Fijałkowski; Andrzej Rynkiewicz; Grzegorz Raczak; Marcin Gruchała
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

6.  Desialylation of platelet surface glycans enhances platelet adhesion to adsorbent polymers for lipoprotein apheresis.

Authors:  Lucia Lauková; René Weiss; Vladislav Semak; Viktoria Weber
Journal:  Int J Artif Organs       Date:  2020-11-03       Impact factor: 1.595

Review 7.  Role of Lipid-Lowering Therapy in Peripheral Artery Disease.

Authors:  Agastya D Belur; Aangi J Shah; Salim S Virani; Mounica Vorla; Dinesh K Kalra
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.